AVEO - AVEO Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5150.67M
Enterprise Value 3129.78M
Trailing P/E N/A
Forward P/E 1-5.51
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)24.05
Price/Book (mrq)93.73
Enterprise Value/Revenue 320.72
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.61
52-Week Change 3-68.10%
S&P500 52-Week Change 34.18%
52 Week High 33.5900
52 Week Low 30.4900
50-Day Moving Average 30.7035
200-Day Moving Average 30.7555

Share Statistics

Avg Vol (3 month) 32.91M
Avg Vol (10 day) 38M
Shares Outstanding 5160.74M
Float 134.84M
% Held by Insiders 10.28%
% Held by Institutions 132.51%
Shares Short (Aug 15, 2019) 417.94M
Short Ratio (Aug 15, 2019) 46.97
Short % of Float (Aug 15, 2019) 413.31%
Short % of Shares Outstanding (Aug 15, 2019) 411.16%
Shares Short (prior month Jul 15, 2019) 419.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -46.69%
Operating Margin (ttm)-388.65%

Management Effectiveness

Return on Assets (ttm)-49.35%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)6.26M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)62.40%
Gross Profit (ttm)-15.24M
EBITDA N/A
Net Income Avi to Common (ttm)-2.92M
Diluted EPS (ttm)-0.1010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.23M
Total Cash Per Share (mrq)0.25
Total Debt (mrq)19.34M
Total Debt/Equity (mrq)1,184.57
Current Ratio (mrq)2.21
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-23.89M
Levered Free Cash Flow (ttm)-17.65M